IP Library › Granted Patent US 12,385,045
Granted Patent B2
US 12,385,045 · App. 17/687,473 · Granted Aug 12, 2025

Thermostable polymerase inhibitor compositions and methods

Inventors: Sergey G. Lokhov (Seattle, WA); Alexander A. Gall (Woodinville, WA); Vera Baraznenok (Sunnyvale, CA); Ekaterina V. Viazovkina (Sunnyvale, CA); Irina Shishkina (Sunnyvale, CA); David H. Persing (San Martin, CA)
Assignee: Cepheid
C12N15/115C12Q1/6853C12Q1/686C12N2310/16C12N2310/531C12N2310/532C12N2320/52C12Q2525/205
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,385,045
App. No.
17/687,473
Granted
Aug 12, 2025
Kind
B2
Abstract

The present disclosure relates to aptamers for temperature-dependent reversible inhibition of thermostable polymerase activity in order to improve sensitivity and specificity of various reactions and assays involving hot start polynucleotide synthesis. Methods for use of the aptamers and related compositions and kits are also provided.

Claims (116)

1. A dumbbell aptamer comprising

a single oligonucleotide in a folded configuration, the single oligonucleotide comprising

nucleotides of SEQ ID NO:1, or a variant thereof, covalently linked to

nucleotides of SEQ ID NO:3, or a variant thereof, covalently linked to

nucleotides of SEQ ID NO:2, or a variant thereof, covalently linked to

nucleotides of SEQ ID NO:3, or the variant thereof;

in the folded configuration the single oligonucleotide comprises

a nucleotide stem and two nucleotide loops,

wherein the nucleotide stem comprises

the nucleotides of SEQ ID NO:1, or the variant thereof,

hybridized to

the nucleotides of SEQ ID NO:2, or the variant thereof,

wherein the nucleotides of

SEQ ID NO:1, or the variant thereof, or

SEQ ID NO:2, or the variant thereof,

are split into

a 5′ portion and

a 3′ portion

due to a lack of a covalent bond between adjacent nucleotides of

SEQ ID NO:1 or the variant thereof, or

SEQ ID NO:2, or the variant thereof,

the lack of the covalent bond defining

a 5′ terminus and

a 3′ terminus

of the dumbbell aptamer that are positioned adjacent to one another within the nucleotide stem of the single oligonucleotide in the folded configuration,

wherein:

the variant of SEQ ID NO: 1 has only 1 to 4 nucleotide substitutions in SEQ ID NO:1;

the variant of SEQ ID NO:2 has only 1 to 4 nucleotide substitutions in SEQ ID NO:2;

the variants of SEQ ID NO: 1 and SEQ ID NO:2 are

equal in length to each other, and are

100% complementary to each other along their entire length; and

each of the two nucleotide loops of the single oligonucleotide, in the folded configuration, individually comprise

SEQ ID NO:3, or variants thereof,

the variants of SEQ ID NO:3 having only 1 or 2 nucleotide substitutions in SEQ ID NO: 3.

2. The dumbbell aptamer of claim 1 , wherein

the nucleotides of SEQ ID NO:1, or the variant thereof, are

split into

the 5′ portion and

the 3′ portion,

defining

the 5′ terminus and

the 3′ terminus

within SEQ ID NO:1 or the variant thereof.

3. The dumbbell aptamer of claim 1 , wherein

the nucleotides of SEQ ID NO:2, or the variant thereof, are

split into

the 5′ portion and

the 3′ portion,

defining

the 5′ terminus and

the 3′ terminus

within SEQ ID NO:2 or the variant thereof.

4. The dumbbell aptamer of claim 2 , wherein the nucleotides of SEQ ID NO: 1 lack said covalent bond between nucleotides 8 and 9.

5. The dumbbell aptamer of claim 3 , wherein the nucleotides of SEQ ID NO: 2 lack said covalent bond between nucleotides 8 and 9.

6. The dumbbell aptamer of claim 2 , wherein:

the 5′ terminus, is phosphorylated;

the 3′ terminus is linked to a 3′ capping moiety;

the 5′ terminus, is linked to a 5′ capping moiety; or

the 3′ terminus is linked to the 3′ capping moiety and the 5′ terminus, is linked to the 5′ capping moiety.

7. The dumbbell aptamer of claim 6 , wherein

the 3′ capping moiety is

a propanediol spacer (C3) or

a phosphate.

8. The dumbbell aptamer of claim 6 , wherein

the 5′ capping moiety is an amino group.

9. The dumbbell aptamer of claim 3 , wherein:

the 5′ terminus is phosphorylated;

the 3′ terminus is linked to a 3′ capping moiety;

the 5′ terminus is linked to a 5′ capping moiety; or

the 3′ terminus is linked to the 3′ capping moiety and the 5′ terminus is linked to the 5′ capping moiety.

10. The dumbbell aptamer of claim 9 , wherein

the 3′ capping moiety is

a propanediol spacer (C3) or

a phosphate.

11. The dumbbell aptamer of claim 9 , wherein the 5′ capping moiety is an amino group.

12. A composition comprising

the dumbbell aptamer according to claim 1 and

a thermostable polymerase.

13. The composition of claim 12 , wherein

the molar ratio of

the dumbbell aptamer to

the thermostable polymerase

ranges from

about 2:1 to

about 15:1.

14. The composition of claim 12 , wherein

the molar ratio of

the dumbbell aptamer to

the thermostable polymerase

is about 1:1, 2:1 or 4:1.

15. An aptamer consisting of SEQ ID NO: 110 wherein the 5′ and 3′ ends are ligated.

16. An aptamer comprising SEQ ID NO: 106 or a variant thereof; and

the aptamer further comprising a secondary structure comprising

two nucleotide loops and

a nucleotide stem;

wherein the variant of SEQ ID NO:106 comprises

fewer than 3 nucleotide substitutions in each of the two nucleotide loops,

fewer than 9 nucleotide substitutions in the nucleotide stem, and

fewer than 13 nucleotide substitutions in total.

17. A method for extending a primer, the method comprising

contacting a sample which might contain a target nucleic acid with a reagent composition to generate a reaction mixture;

wherein the reagent composition comprises

the dumbbell aptamer according to claim 1 ,

a thermostable polymerase,

a forward primer specific for the target nucleic acid,

deoxyribonucleotide triphosphates, and

a divalent metal cation.

18. The method of claim 17 , wherein

the ratio of

the dumbbell aptamer to

the thermostable polymerase

ranges from about 2:1 to 15:1.

19. The dumbbell aptamer of claim 1 , wherein

the single oligonucleotide is at least a 56-mer.

20. The dumbbell aptamer of claim 1 , wherein

the single oligonucleotide comprises SEQ ID NO:106.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2025
From: LOKHOV, SERGEY G.; GALL, ALEXANDER A.; BARAZNENOK, VERA; VIAZOVKINA, EKATERINA V.; SHISHKINA, IRINA; PERSING, DAVID H.
To: CEPHEID
Reel/Frame 071663/0460 →
Continuity (3)
Continuation 16305858
Provisional Application 62347004 · Jun 7, 2016
Related Publication 20220389427A1 · Dec 8, 2022
References Cited (32)
US 5874557A · Gold et al. · 1999 [cited by applicant]
US 6183967B1 · Jayasena et al. · 2001 [cited by applicant]
US 6667165B2 · Peters · 2003 [cited by applicant]
US 8313932B2 · Moser et al. · 2012 [cited by applicant]
US 8530194B2 · Mao et al. · 2013 [cited by applicant]
US 10689629B1 · Kutyavin et al. · 2020 [cited by applicant]
US 10724017B1 · Kutyavin et al. · 2020 [cited by applicant]
US 10724083B1 · Kutyavin et al. · 2020 [cited by applicant]
US 11155859B2 · Kutyavin et al. · 2021 [cited by applicant]
US 11299739B2 · Lokhov et al. · 2022 [cited by applicant]
US 20010053519A1 · Fodor · 2001 [cited by examiner]
US 20150176059A1 · Fiss et al. · 2015 [cited by applicant]
US 20190316132A1 · Lokhov et al. · 2019 [cited by applicant]
US 20200392471A1 · Kutyavin et al. · 2020 [cited by applicant]
US 20200392561A1 · Kutyavin et al. · 2020 [cited by applicant]
JP 2016540517A · 2016 [cited by applicant]
WO WO0052207A1 · 2000 [cited by applicant]
WO WO2006086669A2 · 2006 [cited by applicant]
WO WO2007041201A2 · 2007 [cited by examiner]
WO WO2015091720A1 · 2015 [cited by applicant]
WO WO2016072758A1 · 2016 [cited by applicant]
WO WO2017214202A1 · 2017 [cited by applicant]
Chou et al. (1992) “Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications” Nucleic Acids Research 20(7): 1717-1723. [cited by applicant]
Dorjsuren et al. (2009) “A real-time fluorescence method for enzymatic characterization of specialized human DNA polymerases” Nucleic Acids Research 37(19): e128 (12 pages). [cited by applicant]
Giusto, D. and King, G.C. “Construction, Stability, and Activity of Multivalent Circular Anticoagulant Aptamers”, The Journal of Biological Chemistry, 2004, vol. 279, No. 45, pp. 46463-46489. [cited by applicant]
Lin, Y. and Jayasena, S.D. “Inhibition of Multiple Thermostable DNA Polymerases by a Heterodimeric Aptamer”, 1997, Journal of Molecular Biology, vol. 271, pp. 100-111. [cited by applicant]
Ma et al. (2006) “Real-time monitoring of DNA polymerase activity using molecular beacon” Analytical Biochemistry 353: 141-143. [cited by applicant]
Nikiforov (2011) “Fluorogenic polymerase, endonuclease, and ligase assays based on DNA substrates labeled with a single fluorophore” Analytical Biochemistry 412: 229-236. [cited by applicant]
Nikiforov (2012) “Fluorogenic substrates with single fluorophores for nucleic acid-modifying enzymes: Design principles and new applications” Analytical Biochemistry 424: 142-148. [cited by applicant]
Notice of Allowance dated Dec. 2, 2021 in U.S. Appl. No. 16/305,858. [cited by applicant]
Summerer and Marx (2002) “A Molecular Beacon for Quantitative Monitoring of the DNA Polymerase Reaction in Real-Time” Angewandte Chemie International Edition 41(19): 3620-3622. [cited by applicant]
Yakimovich, O.Y. et al., “Influence of DNA Aptamer Structure on the Specificity of Binding to Taq DNA Polymerase” Biochemistry, 2003, vol. 68, No. 2, pp. 228-235. [cited by applicant]